Pulmonary alveolar microlithiasis (PAM) is a rare genetic lung disease characterized by
calcifications within the alveoli. Mutations in the SLC34A2 gene, which encodes a type IIb …

The world of rare interstitial lung diseases (ILDs) is diverse and complex. Diagnosis and
therapy usually pose challenges. This review describes a selection of rare and ultrarare …

The aphorism that children are not little adults certainly applies for the imaging of interstitial
lung disease. Acquiring motion-free images of fine pulmonary structures at desired lung …

The gene responsible for PAM, SLC34A2, has been identified. It encodes a type IIb sodium-
dependent phosphate transporter, the function of which provides an insight into the …

Pulmonary alveolar microlithiasis (PAM) is a fascinating rare lung disease that is associated
with the accumulation of hydroxyapatite microliths within the lumen of the alveolar spaces. In …

Pulmonary alveolar microlithiasis is a rare diffuse lung disease characterised by deposition
of calcium phosphate within the alveolar airspaces. The disease is usually discovered from …

Pulmonary alveolar microlithiasis (PAM) is a rare disease in which calcium-phosphate
microliths accumulate within the alveolar space. We report cases of 2 siblings with PAM …

BACKGROUND:: In several studies, it was shown that there was a marked decrease in
serum levels of HDL-C during infection and inflammation in general. In particular, a …

Pulmonary alveolar microlithiasis (PAM) is a rare autosomal recessive disorder
characterized by the deposition of calcium phosphate microliths throughout the lungs …

Objective: To present the high-resolution computed tomography (HRCT) findings of
pulmonary alveolar microlithiasis. Methods: The HRCT scans of 10 adult patients (seven …